OR WAIT null SECS
October 07, 2021
The $3 million investment will go towards various projects investigating key product attributes for therapeutic proteins.
The agency’s human medicines committee approved an additional site in West Point, Pa. in the United States for the manufacture of Janssen’s COVID-19 vaccine.
The agency has concluded that an extra dose of the COVID-19 vaccines may be given to those individuals with severely weakened immune systems.
The agency received a marketing authorization application a monoclonal antibody treatment for COVID-19 patients.
October 06, 2021
New excipients for protein-based drug products reduce viscosity while maintaining protein stability.
Moderna’s new 462,000-ft² science center is expected to be completed by 2023.
The collaboration between Sunovion, Sumitomo Dainippon, and Otsuka will focus on four compounds designed to treat neuropsychiatric health conditions.
The test developed by Luas Diagnostics and Bond Digital uses a smartphone app to enhance a 15-minute COVID-19 immunity test.
October 05, 2021
Merck and Ridgeback Biotherapeutics' oral antiviral medication reduced the risk of hospitalization or death from COVID-19 by 50% relative to placebo in a Phase III clinical study.
October 04, 2021
Certara’s acquisition of Pinnacle 21 grants them access to their compliance validation software.